7145-46-2

Usage

Uses

Used in Pharmaceutical Industry:
(2E)-2-[cyclopropyl(3,4-dimethylphenyl)methylidene]hydrazinecarbothioamide is used as a potential therapeutic agent for its ability to inhibit MDR 1 P-glycoprotein, which can help overcome multidrug resistance in cancer treatment. Its antibacterial, antifungal, and antitumor properties also make it a candidate for the development of new drugs to combat various diseases and infections.
Used in Cancer Research:
In cancer research, (2E)-2-[cyclopropyl(3,4-dimethylphenyl)methylidene]hydrazinecarbothioamide is used as a potential antitumor agent due to its ability to target and inhibit MDR 1 P-glycoprotein, a protein often associated with resistance to chemotherapy drugs. This property allows the compound to enhance the effectiveness of conventional cancer treatments and improve patient outcomes.
Used in Antibacterial and Antifungal Applications:
(2E)-2-[cyclopropyl(3,4-dimethylphenyl)methylidene]hydrazinecarbothioamide is used as an antibacterial and antifungal agent, leveraging its inherent properties to combat bacterial and fungal infections. Its potential use in these applications can contribute to the development of new treatments for drug-resistant infections.
Used in Drug Resistance Studies:
In drug resistance studies, (2E)-2-[cyclopropyl(3,4-dimethylphenyl)methylidene]hydrazinecarbothioamide is used to investigate the mechanisms of multidrug resistance and develop strategies to overcome it. Understanding its interaction with MDR 1 P-glycoprotein can provide insights into the development of new drugs that can bypass resistance mechanisms in various diseases.